Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from JNJ

3 Blue-Chip Dividend Stocks for a Secure Retirement Portfolio

Blue-chip dividend stocks are of well-established companies offering steady income and financial stability. They are ideal for securing a resilient retirement portfolio, combining consistent dividends with potential capital appreciation. Thus, quality blue-chip dividend stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and McDonald’s (MCD) could be ideal portfolio additions for retirement…

StockNews.com

Is It Time to Buy These Overlooked Dividend Stocks?

These defensive healthcare picks from the Dow Jones Industrial Average are worth a look at current levels for investors seeking passive income.

Barchart

3 Must-Buy Healthcare Stocks for Defensive Investing

The healthcare sector is set for significant growth due to advancements in pharma technology, increasing demand for personalized medicines, and resilience even in economic downturns. Therefore, investors might consider buying quality pharmaceutical stocks like Pfizer (PFE), Johnson & Johnson (JNJ), and AbbVie (ABBV) for defensive investing. Read on.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Top Stocks for Dividend Reinvestment Plans (DRIPs)

DRIPs offer a compelling strategy to boost investment returns. This approach helps to compound your gains over time by reinvesting dividends to buy more stock and reducing risk through dollar-cost investing. Top stocks, including Johnson & Johnson (JNJ), Coca-Cola (KO), and PepsiCo (PEP), are ideal for reinvesting dividends to maximize…

StockNews.com

Is Wall Street Bullish or Bearish on Johnson & Johnson Stock?

Despite Johnson & Johnson’s relative underperformance over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

3 Healthcare Stocks Benefiting From an Aging Population

The healthcare industry is set for growth due to the growing demand for quality healthcare services and the aging population. Hence, quality healthcare stocks, such as Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co. (MRK), might be worth looking into. Read more….

StockNews.com

3 Pharmaceutical Stocks With Strong Pipelines

The pharmaceutical industry is flourishing due to increasing medical demands and rising healthcare spending worldwide. Hence, pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck & Co. (MRK), with strong pipelines, might be worth buying. Read more….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Stock Market Today: Semis Get Slammed and Blue Chips Bounce

The potential for more curbs on tech sales to China set off a rotation into blue chips.

Kiplinger

3 Blue-Chip Stocks to Buy and Hold Forever

Amidst market uncertainty, blue-chip stocks provide stability, diversification, and reliable returns. Therefore, Johnson & Johnson (JNJ), International Business Machines (IBM), and AT&T (T) could be wise picks to buy and hold forever for smart investors. Read on.

StockNews.com

Johnson & Johnson Earnings Preview: What to Expect

Johnson & Johnson is expected to release its second-quarter earnings next week, and analysts project a low single-digit profit dip.

Barchart

3 Healthcare Stocks With Strong Profit Margins to Buy Now

The healthcare industry is poised to grow rapidly due to the rising need for medical aid, government initiatives, and increasing chronic diseases contributing to overall stability. Given the industry’s promising prospects, investors could consider buying quality healthcare stocks: UnitedHealth Group (UNH), Johnson & Johnson (JNJ), and AbbVie (ABBV), with strong…

StockNews.com

3 Blue-Chip Stocks Offering Stability

Blue-chip companies, characterized by large capitalization, global footprint, solid financial performance, robust balance sheet, and dominant market position, are favored by investors seeking stability and long-term growth potential. Thus, quality blue-chip stocks Microsoft (MSFT), Procter & Gamble (PG), and Johnson & Johnson (JNJ) could be attractive buys for steady returns.…

StockNews.com

How Is Johnson & Johnson's Stock Performance Compared to Other Pharmaceutical Stocks?

Johnson & Johnson has recently underperformed other pharmaceutical stocks. However, Wall Street analysts are moderately optimistic about the stock’s prospects.

Barchart

Top 4 Pharma Stocks for Long-Term Value Investors in 2024

The pharmaceutical sector is experiencing rapid growth thanks to the rising demand for precision drugs, the growing geriatric population, and an uptick in chronic diseases. Given this backdrop, long-term value investors could consider buying and holding quality pharmaceutical stocks such as Organon (OGN), Procaps (PROC), Johnson & Johnson (JNJ), and…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Are Wall Street Analysts Bullish on Johnson & Johnson Stock?

As Johnson & Johnson trails the broader market, Wall Street analysts remain cautiously optimistic about the stock's prospects.

StockNews.com

JNJ Earnings Forecast - Is Pharmaceutical Industry Set for Shake-up?

As pharma titan Johnson & Johnson (JNJ) gears up to unveil its first-quarter results on April 16, 2024, anticipation looms over the pharmaceutical industry. JNJ’s recent acquisitions signal the company’s strategic expansions, and given its history as one of the prominent pharma companies, is JNJ’s forecast as stunning? Let us…

StockNews.com

4 Pharma Giants Sparking Investor Interest

The pharmaceutical industry is growing steadily, focusing more on technological innovation, precision medicine, and strategic mergers and acquisitions (M&A). So, let’s take a look at pharma giants Novo Nordisk A/S (NVO), Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) igniting investor interest. Keep reading….

Top News

Johnson & Johnson Poised For Growth Despite Recent Challenges

Johnson & Johnson (NYSE: JNJ) poised for growth despite challenges, with analysts estimating a 10% upside. Resilient in market fluctuations, key drivers in...

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

4 Pharma Titans Making Waves in Wall Street

The pharma industry is well-positioned to remain buoyed, owing to the rise in chronic diseases, a growing elderly population, and the integration of advanced technologies. Given this backdrop, quality pharma stocks Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ), Novartis AG (NVS), and Merck & Co. (MRK), making waves in…

StockNews.com

3 Pharma Stocks With Prescription for Stability and Value in March

Amid rising healthcare demand globally, advancements in precision medicine, and the booming e-pharmacy market, the pharmaceutical industry is expected to witness significant long-term growth. Hence, fundamentally sound pharma stocks Dr. Reddy’s Laboratories (RDY), Ipsen (IPSEY), and Johnson & Johnson (JNJ), which boast low beta values and attractive valuation metrics, might…

Barchart

4 Top Dividend Kings to Earn Passive Income

Dividend Kings are companies with a long history of paying and increasing shareholder dividends, which signals strong financial health for investors looking to build a steady stream of passive income.

StockNews.com

Pfizer (PFE) vs. Johnson & Johnson (JNJ) - Analyzing Pharma Stocks for Upside Potential

The pharmaceutical industry is expected to witness robust growth over the coming years due to growing healthcare needs and advancements in technology. Given this positive backdrop, let’s analyze the upside potential of pharma stocks Pfizer (PFE) and Johnson & Johnson (JNJ).

StockNews.com

3 Pharma Stock Buys With Accelerating Gains

The pharmaceutical industry is expected to thrive as demand increases and technology advances. Therefore, fundamentally strong pharma stocks Neurocrine Biosciences (NBIX), AstraZeneca (AZN) and Johnson & Johnson (JNJ) might be ideal additions to your portfolio for gains. Read on.

StockNews.com

Johnson & Johnson (JNJ): Analyzing Signals Before Quarterly Earnings

Pharmaceutical powerhouse Johnson & Johnson (JNJ) is proactively driving innovation throughout the healthcare spectrum, thanks to its strong focus on innovative medicines and MedTech solutions. However, with the company’s fiscal fourth-quarter earnings on the horizon, could the stock be a wise portfolio addition? Keep reading to find out….

StockNews.com

What’s the Best 2024 Pharma Stock Buy Among These 3 Stocks?

The pharma industry's potential for sustained growth is reinforced by an aging population, escalating healthcare demands, and the increase in chronic diseases. Therefore, let’s assess the fundamentals of pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Abbvie (ABBV) to determine the most promising choice for the current year….

1 … 5 6 7 8

People

Kritika SarmahHer

727 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Disease

15,705 stories

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.